A study on male rats and ulcerative colitis concludes that krill oil supplementation may reduce markers of inflammation and improve colon length in rats with the disease.
A study on male rats and ulcerative colitis concludes that krill oil supplementation may reduce markers of inflammation and improve colon length in rats with the disease.
Researchers at the University of Bergen, Norway divided male rats into three groups: a control group, a control group with ulcerative colitis, and a group with ulcerative colitis that consumed krill oil for four weeks. Compared to the control group with the disease, rats supplementing with krill oil experienced significant reductions in several inflammatory markers and increased colon length (reduced colon length is a sign of severity of the disease).
“Previous studies have shown krill oil to have anti-inflammatory effects, but this is the first study to indicate the anti-inflammatory and protein antioxidant properties of krill oil in ulcerative colitis…” said Aker BioMarine (Oslo, Norway) in a recent press release. The company provided krill oil for the study.
Aker adds that ulcerative colitis is a common condition in the United States, where an estimated 1 to 2 million people have the disease.
The recent study was published in the Scandinavian Journal of Gastroenterology.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.
New review paper highlights gut-brain benefits of novel herbal blend, Digexin
September 16th 2024NXT USA has announced the publication of a narrative review that offers an in-depth analysis of the efficacy and safety of its Digexin ingredient, which is a novel blend of Ashwagandha and okra extracts.